PPP1R15A and thyroid gland undifferentiated (anaplastic) carcinoma: Sephin1, a novel GADD34 inhibitor, impedes PP1-GADD34 complex formation and consequent substrate dephosphorylation and inhibits anaplastic thyroid cancer (ATC) growth.